SCHEMBL358896

SCHEMBL358896

CC(C)(O)Cc1ccc(OCCO)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
NR1I2 O75469 1/20 0.49
ALDH1A1 P00352 4/20 0.48
RECQL P46063 1/20 0.48
LMNA P02545 2/20 0.43
MEN1 O00255 1/20 0.43
USP2 O75604 1/20 0.43
MAPK1 P28482 1/20 0.43
CASP1 P29466 1/20 0.43
KMT2A Q03164 1/20 0.43
SLCO1B3 Q9NPD5 1/20 0.43
SLCO1B1 Q9Y6L6 1/20 0.43
HRH3 Q9Y5N1 1/20 0.42
GAA P10253 1/20 0.42
ACACB O00763 1/20 0.40
APP P05067 3/20 0.39
PPARG P37231 1/20 0.37
PPARD Q03181 1/20 0.37
PPARA Q07869 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenoxyethanol SCHEMBL3231357 0.88 RECQL (0.63) CYP3A4SMN1; SMN2NR1I2ALDH1A1RECQL
SCHEMBL12775672 0.87 CYP3A4 (0.59) CYP3A4SMN1; SMN2NR1I2ALDH1A1RECQL
SCHEMBL13819820 0.86 CYP3A4 (0.51) CYP3A4SMN1; SMN2NR1I2ALDH1A1RECQL
SCHEMBL83519 0.86 CYP3A4 (0.50) CYP3A4SMN1; SMN2NR1I2ALDH1A1RECQL
SCHEMBL4538628 0.84 EBP (0.46) CYP3A4SMN1; SMN2LMNAMEN1KMT2A
SCHEMBL21483744 0.84 HRH3 (0.41) CYP3A4SMN1; SMN2ALDH1A1LMNAHRH3
SCHEMBL127434 0.83 CYP3A4 (0.47) CYP3A4SMN1; SMN2NR1I2ALDH1A1RECQL
SCHEMBL10939495 0.82 HRH3 (0.61) CYP3A4SMN1; SMN2NR1I2ALDH1A1RECQL
SCHEMBL788296 0.82 SMN1; SMN2 (0.50) CYP3A4SMN1; SMN2NR1I2ALDH1A1RECQL
SCHEMBL19644362 0.82 SMN1; SMN2 (0.50) CYP3A4SMN1; SMN2NR1I2ALDH1A1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117264110-A Polyacrylic thickener, preparation method thereof and neutral mixed emulsion 江苏耐斯数码科技股份有限公司 2023-12-22 CN claimed
CN-112204088-A Hard coat film and image display device comprising same 东友精细化工有限公司 2021-01-08 CN claimed
EP-2961762-A1 MIXED-MODE CHROMATOGRAPHY MEMBRANES Natrix Separations Inc. (CA) 2016-01-06 EP claimed
CN-104707580-A Method for preparing heavy metal extraction agent microcapsule and application of heavy metal extraction agent microcapsule to heavy metal wastewater treatment UNIV HUIZHOU 2015-06-17 CN claimed
WO-2014134147-A1 MIXED-MODE CHROMATOGRAPHY MEMBRANES NATRIX SEPARATIONS INC. (CA) 2014-09-04 WO claimed
EP-0830676-B1 DIGITAL INFORMATION RECORDING MEDIA AND METHOD OF USING SAME KIMBERLY CLARK CO (US) 2001-08-16 EP claimed
US-20260014805-A1 PHOTOCURABLE INK, INK CARTRIDGE, AND INKJET RECORDING METHOD CANON KK (JP) 2026-01-15 US disclosed
US-20250341667-A1 LIQUID CRYSTAL MATERIAL, LAMINATE, OPTICAL MEMBER, DISPLAY DEVICE AND LAMINATE MANUFACTURING METHOD SAMSUNG ELECTRONICS CO., LTD. (KR) 2025-11-06 US disclosed
WO-2025063031-A1 ACTINIC ENERGY RAY-CURABLE COMPOSITION AND RESIN MOULDED BODY スタンレー電気株式会社 2025-03-27 WO disclosed
US-20250092171-A1 HIGH-PURITY 4-(2-BROMOETHYL)BENZENESULFONIC ACID, HIGH-PURITY STYRENESULFONIC ACID COMPOUND DERIVED THEREFROM, AND POLYMER THEREOF, AND METHODS FOR PRODUCING SAME TOSOH FINECHEM CORPORATION (JP) 2025-03-20 US disclosed
WO-2025041532-A1 ACTIVE ENERGY RAY-CURABLE ANTIFOGGING COMPOSITION AND RESIN MOLDED BODY スタンレー電気株式会社 2025-02-27 WO disclosed
WO-2025041652-A1 ACTIVE ENERGY RAY-CURABLE ANTIFOGGING COMPOSITION AND RESIN MOLDED ARTICLE スタンレー電気株式会社 2025-02-27 WO disclosed
US-12187061-B2 Thermosensitive recording medium and image forming method CANON KABUSHIKI KAISHA (JP) 2025-01-07 US disclosed
WO-2001068722-A1 HYDROGEL BIOMEDICAL ARTICLES BIOCURE, INC. (US) 2001-09-20 WO disclosed
EP-1112307-A1 SCREEN COATING COMPOSITION AND METHOD FOR APPLYING SAME Cognis Corporation (US) 2001-07-04 EP disclosed
WO-2000011068-A1 SCREEN COATING COMPOSITION AND METHOD FOR APPLYING SAME COGNIS CORPORATION (US) 2000-03-02 WO disclosed
EP-0894286-A1 NITRONE COMPOUNDS AS PHOTOPOLYMER POLYMERIZATION INHIBITORS AND CONTRAST ENHANCING ADDITIVES AlliedSignal Inc. (US) 1999-02-03 EP disclosed
WO-1997040421-A1 NITRONE COMPOUNDS AS PHOTOPOLYMER POLYMERIZATION INHIBITORS AND CONTRAST ENHANCING ADDITIVES ALLIEDSIGNAL INC. (US) 1997-10-30 WO disclosed
US-5296511-A Containing organosilazane copolymer, photosensitizer, solvent SHIN-ETSU CHEMICAL CO., LTD. (JP) 1994-03-22 US disclosed
US-5026625-A Photoinitiators for polymerization of ethylenically unsaturated compounds CIBA-GEIGY CORPORATION (US) 1991-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260014805-A1 PHOTOCURABLE INK, INK CARTRIDGE, AND INKJET RECORDING METHOD ATM, ACR, MMAB CYP3A4 365/4885SMN1; SMN2 1887/4885NR1I2 4763/4885
US-20250092171-A1 HIGH-PURITY 4-(2-BROMOETHYL)BENZENESULFONIC ACID, HIGH-PURITY STYRENESULFONIC ACID COMPOUND DERIVED THEREFROM, AND POLYMER THEREOF, AND METHODS FOR PRODUCING SAME BRPF1, WEE2, WEE1 CYP3A4 3122/4885SMN1; SMN2 1231/4885NR1I2 3699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.